Clinical Trials Directory

Trials / Unknown

UnknownNCT06034106

The Effect of Pomegranate (Punica Granatum L.) Peel Compress Application on Pain and Physical Function Status

The Effect of Pomegranate (Punica Granatum L.) Peel Compress Application on Pain and Physical Function Status in Patients With Knee Osteoarthritis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
67 (estimated)
Sponsor
TC Erciyes University · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Accepted

Summary

Osteoarthritis is the most common type of arthritis among rheumatologic diseases. Complementary therapies are one of the effective methods for pain control. This study was planned as a randomized controlled experimental study. For this purpose, patients diagnosed with knee osteoarthritis who applied to the Orthopedics Outpatient Clinic will be included. It was calculated that the study would include at least 67 patients. The study will be collected using patient information form, descriptive characteristics form, Visual Analog Scale (VAS) and WOMAC osteoarthritis application scale. It was planned as a randomized controlled experimental study to evaluate the effect of pomegranate peel (P. granatum) compress application on pain and function status. The study was divided into 3 groups as Pomegranate (Punica granatum) peel compress, hot compress and control group. Pomegranate (Punica granatum) peel compress was applied 3 days a week for 3 weeks by turning the powder into porridge check.

Detailed description

This randomized controlled experimental study was conducted to evaluate the effect of pomegranate (Punica granatum) peel compress application on pain, stiffness and physical function in individuals with knee osteoarthritis.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPomegranate (Punica granatum) peel compressPomegranate (Punica granatum) peel compress was applied 3 days a week for 3 weeks by turning the powder into porridge check.
BEHAVIORALHot compressHot compress was applied 3 days a week for 3 weeks.

Timeline

Start date
2023-04-14
Primary completion
2023-09-30
Completion
2023-10-15
First posted
2023-09-13
Last updated
2023-09-13

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06034106. Inclusion in this directory is not an endorsement.